Despite the rarity of clock gene mutations in malignancies, studies of breast cancer survival trends have revealed that patients with mutations in all central clock genes or all PERs have a lower survival rate than patients without mutations [45,46]. The gene discussed is CLOCK; the disease is breast carcinoma.